key: cord-1002243-mrz0ir69 authors: Villain, Patricia; Carvalho, Andre L.; Lucas, Eric; Mosquera, Isabel; Zhang, Li; Muwonge, Richard; Selmouni, Farida; Sauvaget, Catherine; Basu, Partha title: Cross‐sectional survey of the impact of the COVID‐19 pandemic on cancer screening programs in selected low‐ and middle‐income countries: Study from the IARC COVID‐19 impact study group date: 2021-02-17 journal: Int J Cancer DOI: 10.1002/ijc.33500 sha: 86f48cb9a86e956d4c7a70cf9953bfbca4a85288 doc_id: 1002243 cord_uid: mrz0ir69 We conducted a study to document the impact of COVID‐19 pandemic on cancer screening continuum in selected low‐ and middle‐income countries (LMICs). LMICs having an operational cancer control plan committed to screen eligible individuals were selected. Managers/supervisors of cancer screening programs were invited to participate in an online survey and subsequent in‐depth interview. Managers/supervisors from 18 programs in 17 countries participated. Lockdown was imposed in all countries except Brazil. Screening was suspended for at least 30 days in 13 countries, while diagnostic‐services for screen‐positives were suspended in 9 countries. All countries except Cameroon, Bangladesh, India, Honduras and China managed to continue with cancer treatment throughout the outbreak. The participants rated service availability compared to pre‐COVID days on a scale of 0 (no activities) to 100 (same as before). A rating of ≤50 was given for screening services by 61.1%, diagnostic services by 44.4% and treatment services by 22.2% participants. At least 70% participants strongly agreed that increased noncompliance of screen‐positive individuals and staff being overloaded or overwhelmed with backlogs would deeply impact screening programs in the next 6 months at least. Although many of the LMICs were deficient in following the “best practices” to minimize service disruptions, at least some of them made significant efforts to improve screening participation, treatment compliance and program organization. A well‐coordinated effort is needed to reinitiate screening services in the LMICs, starting with a situational analysis. Innovative strategies adopted by the programs to keep services on‐track should be mutually shared. deficient in following the "best practices" to minimize service disruptions, at least some of them made significant efforts to improve screening participation, treatment compliance and program organization. A well-coordinated effort is needed to reinitiate screening services in the LMICs, starting with a situational analysis. Innovative strategies adopted by the programs to keep services on-track should be mutually shared. 1 The lockdowns and movement restrictions, slowing down of nonemergency services and diversion of fiscal and manpower resources will deeply impact entire continuum of cancer care. 2 The pandemicinduced health crisis will weaken health systems in most low-and middle-income countries (LMICs) that may shift priorities back to infectious disease control. This is likely to have a long-term impact on cancer prevention interventions, including cancer screening, which in turn will widen the existing disparities in oncology care. 3 Economic consequence of the pandemic, with a 5.2% contraction in global gross domestic product (GDP) projected by the World Bank in 2020, is likely to derail resource-intensive public health programs like cancer screening in many limited resourced countries. 4 Some of the LMICs have substantially invested in recent times to improve organization, reach and quality of cancer screening programs. The call for action toward elimination of cervical cancer issued by the World Health Organization (WHO) in 2018 stimulated many LMICs in the pre-COVID times to revise their national cancer control policies and commit resources to improve cervical cancer screening. 5 The COVID-19 induced health crisis is a potential threat to these LMIC initiatives. Research on Cancer (IARC/WHO) aims to document possible impact of the COVID-19 outbreak on cancer screening programs in selected LMICs and also highlight the best practices that some of these countries might have adopted or planned to mitigate the disruptive consequences of the pandemic on cancer screening service. Our research methodology includes conducting a questionnaire survey among the cancer screening program managers that preceded and informed an in-depth interview of each survey participant. We prepared a list of 20 LMICs distributed across Africa, Central and South America, Asia and Europe fulfilling the following criteria: 1. The country should have a national cancer control plan operational in the year 2019. 2. The cancer control plan delineated a strategy to screen the population for at least one common cancer. The source of abovementioned information was the seventh round of noncommunicable diseases country capacity survey, conducted by the WHO in 2019. 6 The only country to be selected from Europe was Romania, which transitioned from upper-middle to a high income country in 2019. 7 We invited the cancer screening program focal point from Ministry of Health (MoH) of each of the 20 identified countries to participate in our study. Their contact details were obtained from WHO regional offices and/or our national collaborators. We requested the focal point to designate an alternative person; in case he/she was not able to participate. The alternative person could be from MoH or an organization external to the Ministry but closely associated with screening program implementation and/or supervision. We sent reminder letters to the focal points not responding within 2 weeks. The screening program in India is administered by the individual states, and the state program focal point is responsible for implementation, data collection and monitoring. We directly approached the focal points of two states situated in different geographic locations (Assam in north-east and Tamil Nadu in South) of India. The interview, which was conducted using a semi-directive guide 1, 9, 10 The survey data were analyzed in Stata 15.1 (StataCorp LP, TX) and presented as proportions. The summary of interview was used to validate responses to the questionnaire and interview by the corresponding participant and report some useful quotes. The study was conducted in 17 countries (85% [17/20] response rate). One country responded too late to be included and two could not participate due to the political unrest in their countries at the time our study was conducted. Among those participating, three belonged to low, seven to medium and another seven to high or very high HDI categories (Table 1) . Age-standardized cancer mortality rates (in 2018) ranged from 51.0/100000 in Sri Lanka to 130.1/100000 in China. 9 The survey questionnaire was filled out between 13 August and 22 September 2020 by 18 cancer screening program focal-points or supervisors from 17 countries. India had two participants, independently reporting for regional programs in the states of Assam and Tamil Nadu. Majority of the survey participants were from MoH, either acting as screening program(s) focal-point ( Availability of cancer screening (administration of screening tests), diagnosis and treatment services on the date of in-depth interview compared to pre-COVID days, rated by the program managers on a continuous scale of 0 (no activities) to 100 (activities normal and same as before), is shown in Table 2 . A few participants changed the rating originally given at the survey during the interview. A rating of ≤50 was given for screening services availability by 11 out of 18 (61.1%) participants and for diagnostic services by 8 (44.4%) participants. The participants from Bangladesh, India (both regional programs) and Honduras (22.2%) suggested a rating of ≤50 for availability of treatment services. The reported impact of COVID-19 outbreak on availability of cancer screening, diagnostic and treatment services was generally more severe in countries with medium HDI compared to those with low or high HDI ( Figure 1 ). The in-depth interviews revealed a number of new strategies that the programs adopted to ensure continuity of services during the lockdown and beyond. These were primarily aimed at encouraging higher participation to screening, improving compliance to management of screen-positive individuals and ensuring access to cancer T A B L E 1 Human development index (HDI), cancer mortality rates, participants' profile, COVID-19 disease profile, the dates of completion of survey and in-depth interview by participating countries (grouped by HDI category and in ascending order of HDI values) T A B L E 2 Information on lockdown and rating of availability of screening, diagnostic and cancer treatment services by the survey participants in the participating countries (grouped by HDI category and in ascending order of HDI value) We listed the factors that could potentially impact cancer screening programs in the near future and asked the study participants to rate their agreement on a continuous scale of 0 to 100 ( Table 4 ). The T A B L E 3 New strategies adopted by the countries to ensure continuity of screening, diagnostic and treatment services during the lockdown and beyond and/or to improve overall program organization The COVID-19 pandemic, described by some as "the worst public health crisis in our generation," has strained health systems to the extreme. Experts had already predicted a negative impact of the pandemic on cancer screening, and our study reported similar concerns expressed by program managers. 11 Almost all the countries included in our study reported suspension of cancer screening for at least a month due to restrictions associated with lockdown, shifting of health priorities to manage SARS-CoV-2 infections and reluctance among the public to visit health facilities. Screening, diagnostic and treatment services restarted at much reduced capacities after withdrawal of lockdown in most of the programs, as has been reported by countries outside our study. A program from east Asia reported a 35% to 60% reduction in the monthly number of women participating in mammography screening during March to May 2020, the peak time of the outbreak, compared to the observed numbers in the past 3 years. 12 Average number of screening mammograms in the Australian breast cancer screening programs drastically reduced to just over 1000 in the month of April 2020 compared to the expected average of over 70 000. 13 A 62% to 96% decrease in lung, cervical, colorectal and breast cancer screening rates has been recently reported over seven states in the United States of America (USA). 14 Even the average number of cancer surgeries being performed in a week in the USA reduced up to 88% during the peak period of the outbreak. 15 Slowing down of cancer screening and deferring diagnostic and treatment services will lead to a surge in the number of cancer deaths, both in high and limited resourced countries. 14, 16 Our study focused on LMICs spread across different continents and belonging to different categories of HDI. Primary reason for selecting these countries was that they were committed to improve quality and reach of cancer screening services before the outbreak struck. Ministry of Public Health of Cameroon initiated a pilot cervical cancer screening program in 2018 using low-cost HPV detection test in West Cameroon and was in the process of scaling up to other regions. 17 Morocco adopted a strategic cancer control plan in 2010 and implemented breast cancer screening with clinical breast examination across all regions of the country. 18 The program achieved more than 60% annual coverage of the target population within 5 years of initiation. 19 Bangladesh has heavily invested in developing infrastructure, human resources and information system over the last 15 years to improve the quality of cervical cancer screening based on visual inspection with acetic acid (VIA) test. 20 The Zambian cervical cancer prevention program strategically leveraged existing antiretroviral therapy and reproductive health infrastructure to scale up VIA "screen and treat" services gradually up to national level. 21 Emerging economies like Brazil, China and India with very heterogenous health care within the country have scaled up breast and cervical cancer screening in recent times with some efforts to improve program organization (strong political commitments, increased funding, more effective T A B L E 4 Degree of agreement of the study participants to a particular factor suggested to have major impact on services associated with cancer screening over next six months at least The study participants rated their agreement on a sliding scale ranging between 0 (do not agree at all) and 100 (completely agree). health information system, etc.). [22] [23] [24] Thailand switched to HPV test from existing cytology-based screening in 2020, after successful implementation of a pilot to demonstrate feasibility and cost-effectiveness. 25 Islamic Republic of Iran has also introduced HPV screening with a home-grown real-time PCR-based test in selected regions. 26 Honduras and Bhutan implemented and evaluated HPV screening in selected areas and Bhutan was planning to scale up nationally. 27, 28 Colorectal cancer screening program is being implemented as pilots in Morocco and Islamic Republic of Iran and is in the process of being scaled up in Thailand. These LMIC programs are likely to be much less resilient and less prepared to overcome such a major public health crisis, compared to the programs ongoing in the high-income countries. The program focal points participating in our study have expressed very valid concerns about several factors that would disrupt screening services further in the short term, at least. The study participants were concerned that the uncertainties aris- Our study revealed deficiencies in the programs in following some of the best practices recommended to continue with nonemergency services in the "new normal" situation. Regular and accurate public health messages from the MoH tailored toward general public as well as various levels of service providers on stoppage and initiation of services is key to maintain coordination. Many programs were not following this. Programs were deficient in providing training of staff on the specific measures to be adopted to minimize transmission risk during screening related interactions, ensuring regular and adequate supply of PPEs, masks and sanitizers and having a contingency plan to reduce backlogs. Our study revealed a few silver linings in the midst of the disruptions as well. The strategies adopted by some of the programs to maintain services during the acute phase of the pandemic and its aftermath are not only innovative, but also can significantly improve the quality and reach of screening, if sustained over long term. Restarting cancer screening activities as the crisis situation somewhat settles down will require a well-coordinated effort to reach out to the community more proactively, alleviate concerns of the apparently healthy individuals to return to routine health care and reorganize clinical services to minimize backlogs in services, especially cancer treatment. There is an urgent need for every screening program to perform a thorough situational analysis to quantify impact of the pandemic from health systems perspectives, focusing on governance, finance, workforce, infrastructure and services, information system and quality assur- Supporting health-care workers to tide over the increased work pressure and protecting them from getting infected will be key to improve health system capacity. Additional funding is necessary to build a resilient primary health system to improve people's access to much needed preventive health care. Reallocating at least an additional 1% of GDP of public spending for primary care is within reach in all countries and should be seriously considered. 31 The authors declared no potential conflicts of interest. Where authors are identified as personnel of the International Agency for Research on Cancer/World Health Organization, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy, or views of the International Agency for Research on Cancer/World Health Organization. The data that support the findings of this study are available on request from the corresponding author. Ethical approval for our study was obtained from the IARC Ethics Committee. In the email invitation sent to participants, an information sheet was attached describing the study objectives and methodology. The participant had to sign an informed consent electronically, before being able to initiate the survey. Also, at the beginning of the Zoom or WhatsApp calls, verbal consent from the participant was obtained before recording the interview. Only fully anonymized data were received, stored and handled at IARC in a central secure server. Data will be archived at IARC to allow retrieval for any scientific or regulatory external audits. https://orcid.org/0000-0003-0124-4050 World Health Organization. WHO Coronavirus disease (COVID-19) dashboard Managing cancer center during the SARS-COVID-19 pandemic: Moroccan experience COVID-19 and racial/ethnic disparities The global economic outlook during the COVID-19 pandemic: a changed world Elimination of cervical cancer: challenges for developing countries World Health Organization. Noncommunicable diseases and their risk factors. Assessing national capacity for the prevention and control of NCDs (who.int) Romania's priorities include investments in infrastructure, health care, education, job creation, and small and medium enterprise development. The country's economic growth has been one of the highest in the EU since REDCap consortium the REDCap consortium: building an international community of software platform partners Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer United Nations Development Programme Has COVID-19 subverted global health? Impact of the COVID-19 pandemic on a population-based breast cancer screening program. Cancer Australian Institute of Health and Welfare. BreastScreen Australia monitoring report; 2020. BreastScreen Australia monitoring report 2020, Table of contents -Australian Institute of Health and Welfare (aihw.gov.au) Cancer screening during the coronavirus Disease-2019 pandemic: a perspective from the National Cancer Institute's PROSPR consortium Non-emergency procedure volumes in the wake of COVID-19. EHRN. Non-Emergency Procedure Volumes in the Wake of COVID-19 (ehrn.org) The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study Scaling up community-based cervical cancer screening in Cameroon employing a single visit approach Tackling cancer burden in low-income and middle-income countries: Morocco as an exemplar Breast cancer screening program in Morocco: status of implementation, organization and performance Program organization rather than choice of test determines success of cervical cancer screening: case studies from Bangladesh and India Scaling up proven innovative cervical cancer screening strategies: challenges and opportunities in implementation at the population level in low-and lower-middle-income countries Trend analysis of the quality indicators for the Brazilian cervical cancer screening programme by region and state from National screening programs for cervical cancer in Asian countries Healthy China 2030: moving from blueprint to action with a new focus on public health Cost effectiveness analysis of HPV primary screening and dual stain cytology triage compared with cervical cytology Cervical Cancer Screening in Iran: Developing a New Method. FC 21-10 Cervical cancer screening in rural Bhutan with the careHPV test on self-collected samples: an ongoing cross-sectional, population-based study (REACH-Bhutan) Recall efforts successfully increase follow-up for cervical cancer screening among women with human papillomavirus in Honduras Factors predicting delayed presentation of symptomatic breast cancer: a systematic review Influence of delay on survival in patients with breast cancer: a systematic review World Health Organization. Primary Health Care on the Road to Universal Health Coverage Additional supporting information may be found online in the Supporting Information section at the end of this article.How to cite this article: Villain P, Carvalho AL, Lucas E, et al. pandemic on cancer screening programs in selected low-and middle-income countries: Study from the IARC COVID-19 impact study group. Int. J. Cancer. 2021;1-11. https://doi.org/ 10.1002/ijc.33500